APR 29, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Carbamazepine (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling changes for carbamazepine extended-release tablets; does not report clinical trial outcomes or efficacy data.
Reported
Approval date2026-04-29
Product strengths approved100 mg, 200 mg, 400 mg extended-release tab…